47045-QRB-C-CVC-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Multi-country Caribbean strategic response towards HIV/TB elimination in the region - Caribbean - Multicountry Caribbean MCC (01-Apr-2025-31-Dec-2027)</narrative> Multicountry Caribbean MCC, TB/HIV, Caribbean Vulnerable Communities Goal: Establish seamlessly integrated, person-centred healthcare services that prioritize the health and well-being of persons living with HIV and key populations by ensuring access to a comprehensive package of services including combination prevention and differentiated service delivery for treatment and management of STIs, TB and NCDs. Objectives: To increase the number of key populations accessing differentiated prevention, testing and treatment services; To continue implementation of the TB elimination framework for low incidence countries to accelerate the elimination of TB in the OECS; To increase access to quality laboratory testing, screening and diagnosis for the clinical management of HIV, TB, STIs and NCDs; To strengthen the integration of HIV, STI and TB programs into primary health care to ensure that comprehensive, high quality care is provided for individuals co-infected with HIV, TB and STIs; To improve HIV/STI /TB surveillance systems to increase the availability of data to support evidence-based planning, measure the impact of the response and the achievement of targets; To strengthen the health and community systems response to address human rights and gender inequality barriers. The Global Fund to Fight AIDS, Tuberculosis and Malaria Caribbean Vulnerable Communities Caribbean Vulnerable Communities The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Marcos Patino Mayer Fund Portfolio Manager +41 58 791 1700 marcos.patinomayer@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Multicountry Caribbean MCC HIV Multicomponent, RSSH Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing for AGYW and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs HIV -> Differentiated HIV Testing Services -> Community-based testing outside of KP and AGYW programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs HIV -> Differentiated HIV Testing Services -> Self-testing for AGYW and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Self-testing for KP programs HIV -> Differentiated HIV Testing Services -> Self-testing outside of KP and AGYW programs HIV -> Prevention package for other vulnerable populations (OVP) -> Community empowerment for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> Condom and lubricant programming for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> HIV prevention communication, information and demand creation for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> Pre-exposure prophylaxis (PrEP) programming for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring rights-based law enforcement practices HIV -> Reducing human rights-related barriers to HIV/TB services -> Improving laws, regulations and policies relating to HIV and HIV/TB HIV -> Reducing human rights-related barriers to HIV/TB services -> Increasing access to justice (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy ("Know Your Rights") (HIV/TB) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children) HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Laboratory supply chain systems RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: National laboratory governance and management structures RSSH -> RSSH/PP: Laboratory systems (including national and peripheral) -> RSSH/PP: Quality management systems and accreditation RSSH -> RSSH: Community systems strengthening -> Capacity building and leadership development RSSH -> RSSH: Community systems strengthening -> Community engagement, linkages and coordination RSSH -> RSSH: Community systems strengthening -> Community-led monitoring RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use RSSH -> RSSH: Monitoring and evaluation systems -> Data quality RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Children and adolescents Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Mobile population (migrants/refugees/IDPs) Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support Tuberculosis -> TB/DR-TB Prevention -> Preventive treatment Tuberculosis -> TB/DR-TB Prevention -> Screening/testing for TB infection Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis Tuberculosis -> TB/HIV -> TB/HIV - Treatment and care 758688.94 925707.48 978156.13 918175.68 Global Fund commitment to QRB-C-CVCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Caribbean Vulnerable Communities 306058.56 Global Fund disbursement to QRB-C-CVCP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Caribbean Vulnerable Communities 306058.56 Global Fund disbursement to QRB-C-CVCP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Caribbean Vulnerable Communities 306058.56 Global Fund disbursement to QRB-C-CVCP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Caribbean Vulnerable Communities 871109.39 Global Fund commitment to QRB-C-CVCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Caribbean Vulnerable Communities 626570.36 Global Fund disbursement to QRB-C-CVCP01 (International NGO). The Global Fund to Fight AIDS, Tuberculosis and Malaria Caribbean Vulnerable Communities 16220.00 Global Fund disbursement to QRB-C-CVCP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Caribbean Vulnerable Communities 329585.67 Expenditure reported by Caribbean Vulnerable Communities for QRB-C-CVCP01, Apr 2025 to Dec 2025. Caribbean Vulnerable Communities <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. 1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing.  (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons. 2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation. 3 - The Principal Recipient shall not use budget line 122 of the Program budget for US$ 16,942.00, until grant funds savings and/or efficiencies are identified to fully cover this activity, consistent with the Global Fund's policies and the Global Fund's prior written approval. <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: Subnational, less than 100% national program target. Numerator: 180; Denominator: 7210. Numerator: 270; Denominator: 7210. Numerator: 1656; Denominator: 7210. Numerator: 540; Denominator: 7210. Numerator: 1080; Denominator: 7210. <narrative>KP-6 Other- 1: Number of OVP who received any PrEP product at least once during the reporting period</narrative> Module: Prevention package for other vulnerable populations (OVP). <narrative>KP-6 Other- 1: Number of OVP who received any PrEP product at least once during the reporting period</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of other vulnerable people reached with HIV prevention programs</narrative> Module: Prevention package for other vulnerable populations (OVP). <narrative>Percentage of other vulnerable people reached with HIV prevention programs</narrative> Geographic coverage: Subnational, less than 100% national program target. Numerator: 793; Denominator: 7210. Numerator: 1189; Denominator: 7210. Numerator: 1451; Denominator: 7210. Numerator: 1784; Denominator: 7210. Numerator: 2676; Denominator: 7210. <narrative>Number of community organizations that received a pre-defined package of training</narrative> Module: RSSH: Community systems strengthening. <narrative>Number of community organizations that received a pre-defined package of training</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative> Module: RSSH: Monitoring and evaluation systems. <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative> Geographic coverage: National, 100% of national program target. Numerator: 2; Denominator: 6. Numerator: 3; Denominator: 6. Numerator: 3; Denominator: 6. Numerator: 4; Denominator: 6. Numerator: 6; Denominator: 6. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Module: TB diagnosis, treatment and care. <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative> Geographic coverage: National, 100% of national program target. Numerator: 4; Denominator: 8. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Module: TB diagnosis, treatment and care. <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative> Geographic coverage: National, 100% of national program target. Numerator: 5; Denominator: 9. Numerator: 5; Denominator: 8. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Module: TB/DR-TB Prevention. <narrative>Number of people in contact with TB patients who began preventive therapy</narrative> Geographic coverage: National, 100% of national program target. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative> Geographic coverage: National, 100% of national program target. Numerator: 0. Percentage: 100%. Numerator: 79; Denominator: 125; Percentage: 63.2%. Percentage: 100%. Percentage: 100%. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Numerator: 1988; Denominator: 4840. Numerator: 2584; Denominator: 5024. Numerator: 1687; Denominator: 3591. Numerator: 3360; Denominator: 5215. Numerator: 4368; Denominator: 5413.